Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.

A global scientific strategy to cure hepatitis B / Revill, P. A.; Chisari, F. V.; Block, J. M.; Dandri, M.; Gehring, A. J.; Guo, H.; Hu, J.; Kramvis, A.; Lampertico, P.; Janssen, H. L. A.; Levrero, M.; Li, W.; Liang, T. J.; Lim, S. -G.; Lu, F.; Penicaud, M. C.; Tavis, J. E.; Thimme, R.; Arbuthnot, P.; Boonstra, A.; Chang, K. -M.; Chen, P. -J.; Glebe, D.; Guidotti, L. G.; Fellay, J.; Ferrari, C.; Jansen, L.; Lau, D. T. Y.; Lok, A. S.; Maini, M. K.; Mason, W.; Matthews, G.; Paraskevis, D.; Petersen, J.; Rehermann, B.; Shin, E. -C.; Thompson, A.; van Bommel, F.; Wang, F. -S.; Watashi, K.; Yang, H. -C.; Yuan, Z.; Yuen, M. -F.; Block, T.; Miller, V.; Protzer, U.; Brechot, C.; Locarnini, S.; Peters, M. G.; Schinazi, R. F.; Zoulim, F.. - In: THE LANCET. GASTROENTEROLOGY & HEPATOLOGY. - ISSN 2468-1253. - 4:7(2019), pp. 545-558. [10.1016/S2468-1253(19)30119-0]

A global scientific strategy to cure hepatitis B

Levrero M.;
2019

Abstract

Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.
2019
Animals; Antiviral Agents; B-Lymphocytes; Cell Line, Transformed; DNA, Viral; Disease Eradication; Disease Models, Animal; Forecasting; Global Health; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Immunity, Cellular; Immunotherapy; Liver Neoplasms; Remission Induction; Research; T-Lymphocytes; Virus Replication
01 Pubblicazione su rivista::01a Articolo in rivista
A global scientific strategy to cure hepatitis B / Revill, P. A.; Chisari, F. V.; Block, J. M.; Dandri, M.; Gehring, A. J.; Guo, H.; Hu, J.; Kramvis, A.; Lampertico, P.; Janssen, H. L. A.; Levrero, M.; Li, W.; Liang, T. J.; Lim, S. -G.; Lu, F.; Penicaud, M. C.; Tavis, J. E.; Thimme, R.; Arbuthnot, P.; Boonstra, A.; Chang, K. -M.; Chen, P. -J.; Glebe, D.; Guidotti, L. G.; Fellay, J.; Ferrari, C.; Jansen, L.; Lau, D. T. Y.; Lok, A. S.; Maini, M. K.; Mason, W.; Matthews, G.; Paraskevis, D.; Petersen, J.; Rehermann, B.; Shin, E. -C.; Thompson, A.; van Bommel, F.; Wang, F. -S.; Watashi, K.; Yang, H. -C.; Yuan, Z.; Yuen, M. -F.; Block, T.; Miller, V.; Protzer, U.; Brechot, C.; Locarnini, S.; Peters, M. G.; Schinazi, R. F.; Zoulim, F.. - In: THE LANCET. GASTROENTEROLOGY & HEPATOLOGY. - ISSN 2468-1253. - 4:7(2019), pp. 545-558. [10.1016/S2468-1253(19)30119-0]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1479915
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 125
  • Scopus 354
  • ???jsp.display-item.citation.isi??? 322
social impact